Clinical Trial Update: Idarubicin Plus Cytarabine (IA) vs IA Plus Cladribine (IAC) as Induction Regimen to Treat Initially Diagnosed Acute Myeloid Leukemia (AML) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing idarubicin plus cytarabine (IA) versus IA plus cladribine (IAC) as induction therapy for newly diagnosed acute myeloid leukemia has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Cladribine (cladribine)
• Idarubicin (idarubicin)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Acute Myeloid Leukemia | Phase 3 | Status: COMPLETED